BCI
BSX icon

Brinker Capital Investments’s Boston Scientific BSX Stock Holding History

Brinker Capital Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Buy
50,552
+13,150
+35% +$714K 0.02% 757
2026
Q1 		$2.35M Sell
37,402
-26,007
-41% -$2.08M 0.02% 686
2025
Q4 		$6.05M Buy
63,409
+4,923
+8% +$483K 0.04% 363
2025
Q3 		$5.71M Buy
58,486
+21,936
+60% +$2.27M 0.04% 383
2025
Q2 		$3.93M Buy
36,550
+3,165
+9% +$320K 0.03% 480
2025
Q1 		$3.37M Buy
33,385
+2,805
+9% +$282K 0.03% 482
2024
Q4 		$2.73M Buy
30,580
+2,065
+7% +$182K 0.03% 547
2024
Q3 		$2.39M Sell
28,515
-1,979
-6% -$156K 0.02% 602
2024
Q2 		$2.35M Buy
30,494
+2,487
+9% +$182K 0.02% 580
2024
Q1 		$1.92M Sell
28,007
-727
-3% -$46.7K 0.02% 679
2023
Q4 		$1.68M Sell
28,734
-25,365
-47% -$1.35M 0.02% 720
2023
Q3 		$2.86M Sell
54,099
-21,933
-29% -$1.15M 0.03% 461
2023
Q2 		$4.11M Sell
76,032
-36,710
-33% -$1.92M 0.04% 369
2023
Q1 		$5.64M Sell
112,742
-19,550
-15% -$921K 0.07% 248
2022
Q4 		$6.12M Sell
132,292
-5,779
-4% -$250K 0.12% 175
2022
Q3 		$5.35M Buy
138,071
+29,866
+28% +$1.2M 0.11% 179
2022
Q2 		$4.03M Sell
108,205
-3,581
-3% -$146K 0.08% 251
2022
Q1 		$4.95M Buy
111,786
+946
+0.9% +$41K 0.08% 251
2021
Q4 		$4.71M Buy
110,840
+9,572
+9% +$402K 0.07% 290
2021
Q3 		$4.33M Hold
101,268
– – 0.07% 298
2021
Q2 		$4.33M Buy
101,268
+8,952
+10% +$377K 0.06% 345
2021
Q1 		$3.57M Buy
92,316
+65,316
+242% +$2.47M 0.05% 336
2020
Q4 		$971K Sell
27,000
-28,209
-51% -$1.02M 0.02% 694
2020
Q3 		$2.11M Buy
+55,209
New +$2.13M 0.04% 454
2020
Q1 		– Sell
-114
Closed -$5K – 358
2019
Q4 		$5K Hold
114
– – ﹤0.01% 642
2019
Q3 		$5K Hold
114
– – ﹤0.01% 629
2019
Q2 		$5K Hold
114
– – ﹤0.01% 835
2019
Q1 		$4K Hold
114
– – ﹤0.01% 724
2018
Q4 		$4K Hold
114
– – ﹤0.01% 563
2018
Q3 		$4K Buy
+114
New +$3.98K ﹤0.01% 540

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brinker Capital Investments's BSX Position: Q2 2026 in Review

Brinker Capital Investments increased its Boston Scientific (BSX) stake by 35% in Q2 2026, buying an estimated $714K and bringing the position to 50,552 shares worth $2.16M. The position accounts for 0.02% of the portfolio, ranked #757.

Brinker Capital Investments first reported a position in BSX in Q3 2018 and has held it in 30 quarters since. The position peaked at $6.12M in Q4 2022. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Brinker Capital Investments held 50,552 shares of Boston Scientific worth $2.16M as of Q2 2026.
  • Brinker Capital Investments bought 13,150 Boston Scientific shares in Q2 2026, an estimated $714K.
  • Boston Scientific made up 0.02% of Brinker Capital Investments's portfolio in Q2 2026, its #757 holding.
  • Brinker Capital Investments first reported a position in Boston Scientific in Q3 2018 and has held it in 30 quarters since.
  • Brinker Capital Investments's Boston Scientific position peaked at $6.12M in Q4 2022.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.